On Monday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) was -6.92% drop from the session before settling in for the closing price of $47.41. A 52-week range for SWTX has been $28.21 – $62.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 663.47% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 34.71%. With a float of $70.33 million, this company’s outstanding shares have now reached $74.40 million.
In an organization with 368 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 93.07%, operating margin of -145.17%, and the pretax margin is -134.73%.
SpringWorks Therapeutics Inc (SWTX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc stocks. The insider ownership of SpringWorks Therapeutics Inc is 6.15%, while institutional ownership is 105.70%. The most recent insider transaction that took place on Mar 03 ’25, was worth 1,084,592. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $54.23, taking the stock ownership to the 169,712 shares. Before that another transaction happened on Mar 03 ’25, when Company’s Chief Executive Officer sold 49,000 for $54.24, making the entire transaction worth $2,657,656. This insider now owns 954,869 shares in total.
SpringWorks Therapeutics Inc (SWTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.73 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.71% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.48, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.5 million. That was inferior than the volume of 2.47 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.47%. Additionally, its Average True Range was 2.57.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 44.96%, which indicates a significant increase from 4.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.33% in the past 14 days, which was lower than the 78.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.71, while its 200-day Moving Average is $39.17. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $45.50. Second resistance stands at $46.87. The third major resistance level sits at $47.74. If the price goes on to break the first support level at $43.26, it is likely to go to the next support level at $42.39. The third support level lies at $41.02 if the price breaches the second support level.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
There are 74,936K outstanding shares of the company, which has a market capitalization of 3.31 billion. As of now, sales total 191,590 K while income totals -258,130 K. Its latest quarter income was 61,550 K while its last quarter net income were -77,300 K.
